Skip to main content
Premium Trial:

Request an Annual Quote

Definiens Raises $12.9M in Private Financing

NEW YORK (GenomeWeb News) – Definiens today said that it has raised €10 million ($12.9 million) in a private round of financing.

The Munich, Germany-based firm said that it would use the proceeds for commercial expansion of its current business and to develop and commercialize clinical digital pathology products. Its image analysis and data mining tools are used for quantitative digital pathology in life sciences research and for tissue-based diagnostic biomarker development.

The round of financing was led by Gilde Healthcare Partners and included existing investors TVM, Cipio, and members of Definiens' management team.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.